GGrantIndex
← Leaderboards

Cheedy Jaja

Augusta University

$1,315,220
Attributed
$1,315,220
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $381.3K · FY201123
$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$1,315,220 · 3

By mechanism

R21$1,033,564 · 2
K01$281,656 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Resources

Research focus

ResourcesSickle Cell AnemiaTraining ProgramsProgramsTrainingFoundationsEvidence BaseFeasibility StudiesFormative AssessmentDesignEarly DiagnosisAfrica South Of The SaharaEndemic DiseasesEvaluationChildCounselingConsolidated Framework For Implementation ResearchCostCost AnalysisBaseCountryBirthChild HealthClinical Pathways

Grant awards (10)

The Nurse Champion Model for Sickle Cell Disease Early Diagnosis and Care Access$164,475
R21 · FY2023 · DK · contact PI
Integrating Nurse Champion Model for Group Reproductive Genetic Counseling forSickle Cell Hemoglobinopathies into Primary Care: A Pilot Implementation ScienceStudy$155,751
R21 · FY2023 · HG · contact PI
The Nurse Champion Model for Sickle Cell Disease Early Diagnosis and Care Access$176,617
R21 · FY2022 · DK · contact PI
Integrating Nurse Champion Model for Group Reproductive Genetic Counseling forSickle Cell Hemoglobinopathies into Primary Care: A Pilot Implementation ScienceStudy$155,413
R21 · FY2022 · HG · contact PI
Integrating Nurse Champion Model for Group Reproductive Genetic Counseling forSickle Cell Hemoglobinopathies into Primary Care: A Pilot Implementation ScienceStudy$205,163
R21 · FY2021 · HG · contact PI
The Nurse Champion Model for Sickle Cell Disease Early Diagnosis and Care Access$176,144
R21 · FY2021 · DK · contact PI
Integrating Nurse Champion Model for Group Reproductive Genetic Counseling for Sickle Cell Hemoglobinopathies into Primary Care: A Pilot Implementation Science Study$1
R21 · FY2021 · HG · contact PI
Pharmacogenetic Optimization of Analgesic Prescribing in Sickle Cell Disease$93,736
K01 · FY2013 · NR · contact PI
Pharmacogenetic Optimization of Analgesic Prescribing in Sickle Cell Disease$93,960
K01 · FY2012 · NR · contact PI
Pharmacogenetic Optimization of Analgesic Prescribing in Sickle Cell Disease$93,960
K01 · FY2011 · NR · contact PI